Aviron Pharma Overview

  • Founded
  • 2010
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Aviron Pharma General Information

Description

Developer of novel treatments for HCV infection. The company conducts research and development in the field of virology and also develops specific antiviral agents against chronic HCV infection.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Primary Office
  • Khimki Street
  • Working, 2-A, Building. 1
  • Moscow, 141400
  • Russia
+7 8 (000) 000-00-00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aviron Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jan-2015 Completed Out of Business
2. Grant 03-Sep-2010 00000 Completed Startup
1. Early Stage VC Completed Startup
To view Aviron Pharma’s complete valuation and funding history, request access »

Aviron Pharma Executive Team (3)

Name Title Board Seat Contact Info
Oleg Basket Director General
You’re viewing 1 of 3 executive team members. Get the full list »